Following an over 12% decline in the previous session in reaction to updates at the company’s R&D Day event, Moderna ...

Nxera Pharma Co., Ltd. will hold an R&D Day on 6 November 2024 at 16:30 JST. The meeting will be held virtually via Zoom webinar. Please click here to pre-register for the event. Date: Wednesday ...

Heading into Moderna’s third-quarter earnings, investors and analysts will be watching to see how the Cambridge drugmaker ...

Moderna stock tumbled again Friday on a series of downgrades and price-target cuts following a "tough update" at its R&D Day.

and R&D (research and development) has come in below expectations. So it's a combination of factors here." Starboard Value ...

Dr. Matt Barnes, Executive Officer, President of Nxera Pharma UK and Head of R&D Dr. Makoto Sugita, Executive Officer, Chief Medical Officer (CMO) and President of Nxera Pharma Japan Hironoshin ...

Nxera Pharma Co., Ltd. will hold an R&D Day on 6 November 2024 at 16:30 JST. The meeting will be held virtually via Zoom ...

Presentation slides will be made available by 16:00 JST (7:00 GMT) on 6 November through the investor section of the Company's Home Page here. Nxera Pharma (formerly Sosei Heptares) is a technology ...

Nxera Pharma Co., Ltd. will hold an R&D Day on 6 November 2024 at 16:30 JST. The meeting will be held virtually via Zoom webinar. Please click here to pre-register for the event. Dr. Matt Barnes, ...